CANNAINVESTOR Magazine October / November 2016 - Page 80


SPI’s First Product – SOS Pain

SoS Pain, SPI’s first product launch is a proprietary dietary supplement optimized for treatment of pain conditions as a sublingual tablet. Here, you can see that Neurontin, the drug typically prescribed for chronic back pain, alleviates 70 percent of pain at very high doses that would prevent the patient from driving, working or performing any normal activity. CBD at the indicated dose after five days provides the potential for almost complete analgesia with NO side effects. The extent of patient responses may vary, but the initial results are extremely promising.